Aloperine Inhibits ASFV via Regulating PRLR/JAK2 Signaling Pathway In Vitro
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25169083 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Renhao Geng und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China. Hauptthemen laut MEDLINE: Janus Kinase 2, Signal Transduction, Virus Replication, Quinolizidines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, National Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
African swine fever (ASF) has become a global pandemic due to inadequate prevention and control measures, posing a significant threat to the swine industry. Despite the approval of a single vaccine in Vietnam, no antiviral drugs against the ASF virus (ASFV) are currently available. Aloperine (ALO), a quinolizidine alkaloid extracted from the seeds and leaves of bitter beans, exhibits various biological functions, including anti-inflammatory, anti-cancer, and antiviral activities. In this study, we found that ALO could inhibit ASFV replication in MA-104, PK-15, 3D4/21, and WSL cells in a dose-dependent manner without cytotoxicity at 100 μM. Furthermore, it was verified that ALO acted on the co- and post-infection stages of ASFV by time-of-addition assay, and inhibited viral internalization rather than directly inactivating the virus. Notably, RT-qPCR analysis indicated that ALO did not exert anti-inflammatory activity during ASFV infection. Additionally, gene ontology (GO) and KEGG pathway enrichment analyses of transcriptomic data revealed that ALO could inhibit ASFV replication via the PRLR/JAK2 signaling pathway. Together, these findings suggest that ALO effectively inhibits ASFV replication in vitro and provides a potential new target for developing anti-ASFV drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.
- Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Shanghai 200241, China.
ORCID-Profile: Kun Qian, Hongjun Chen, Aijian Qin
Förderung
- National Key Research and Development Program
- National Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Postgraduate Research &Practice Innovation Program of Jiangsu Province
- Jiangsu Co-innovation Centre for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses
- Postgraduate Research &Practice Innovation Program of Jiangsu Province
Zitieren
APA
Geng, R., Shao, H., Qian, K., Chen, H., & Qin, A. (2024). Aloperine Inhibits ASFV via Regulating PRLR/JAK2 Signaling Pathway In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169083
Vancouver
Geng R, Shao H, Qian K, Chen H, Qin A. Aloperine Inhibits ASFV via Regulating PRLR/JAK2 Signaling Pathway In Vitro. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169083
BibTeX
@article{Geng2024,
author = {Geng, Renhao and Shao, Hongxia and Qian, Kun and Chen, Hongjun and Qin, Aijian},
title = {Aloperine Inhibits ASFV via Regulating PRLR/JAK2 Signaling Pathway In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25169083}
}
EUVIMED